FDA Inspection 1163035 - Mohnark Pharmaceuticals Inc - February 25, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mohnark Pharmaceuticals Inc

Record Details

This FDA Inspection record concerns Mohnark Pharmaceuticals Inc, with an inspection on February 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Mohnark Pharmaceuticals Inc
Inspection Date: February 25, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 538c44e9-934f-4fb3-aec9-2f4949f7ce81

Violation Codes5

21 CFR 211.186(b)(4)21 CFR 211.22(c)21 CFR 211.42(a)21 CFR 211.46(b)21 CFR 211.84(d)(2)

Full citation text and observation details available on the Dashboard.